Literature DB >> 29757559

[CT observation of retromaxillary posterior ethmoid].

Jin Feng Liu1, Qi Tong Liu2, Jin Yu Liu3, Zhan Feng Yan4, Ning Yu Wang1.   

Abstract

Objective:To investigate the morphologic characteristics of the retromaxillary posterior ethmoid.Method:A total of 103 outpatients encountered in our hospital during March 2012 and December 2012,who completed paranasal sinus CT examination,were included in this study.Patients had no sinus trauma,surgery or tumor history.Their paranasal sinus CT scans were analyzed from scheduled axial and coronal plane.The incidence and imaging features of the retromaxillary posterior ethmoid were observed.Result:The retromaxillary posterior ethmoid(RMPE)was the posterior ethmoid cell that expanded along the lamina papyracea toward the infraorbital region.RMPE was located behind the posterior wall of the maxillary sinus and under the orbital floor.The occurrence rate of the RMPE was 74.3%.The ethmomaxillary septum is the bony septum the between the maxillary sinus and posterior ethmoid.Anatomical confirmation of RMPE is based mainly on the presence of the ethmomaxillary septum.RMPE is located at the back of ethmomaxillary septum.The sagittal angulation of the ethmomaxillary septum ranged from 22 to 87 degrees,with an average of(50.34±12.10)degrees.
Conclusion: The ethmomaxillary septum is important for anatomic recognition of the RMPE.Accurate identification of the RMPE before ESS can help improve the removal of the posterior ethmoid sinus.

Entities:  

Keywords:  endoscopic sinus surgery; ethmomaxillary septum; maxillary sinus; retromaxillary posterior ethmoid; sinusitis

Mesh:

Year:  2018        PMID: 29757559     DOI: 10.13201/j.issn.1001-1781.2018.02.011

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  1 in total

1.  The imaging anatomy of ethmomaxillary sinus and its impact on chronic rhinosinusitis.

Authors:  Fangwei Zhou; Cheng Cao; Wenjun Fan; Lu Tan; Peiqiang Liu; Hao Lv; Yu Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-02       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.